📰 Nasdaq Elym News
Nasdaq Elym News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Elym. Real-time updates on events, politics, business and more.
December 31, 2023
Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Free Report) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 23,300 shares, a decrease of 30.7% from the November 30th total of 33,600 shares. Based on an average trading volume of 15,100 shares, the days-to-cover ratio is currently 1.5 […]
August 30, 2023
Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Free Report) was the recipient of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 53,200 shares, a decrease of 15.2% from the July 31st total of 62,700 shares. Currently, 0.3% of the shares of the stock are […]
August 13, 2023
Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 31st, there was short interest totalling 62,700 shares, an increase of 91.7% from the July 15th total of 32,700 shares. Based on an average daily volume of 26,800 shares, […]
August 13, 2023
Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Free Report) was the recipient of a significant increase in short interest in the month of July. As of July 31st, there was short interest totalling 62,700 shares, an increase of 91.7% from the July 15th total of 32,700 shares. Currently, 0.4% of the company’s shares are sold short. […]
May 31, 2023
Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Rating) saw a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 18,800 shares, a decline of 5.5% from the April 30th total of 19,900 shares. Currently, 0.1% of the shares of the stock are sold short. Based on […]
May 31, 2023
Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Rating) saw a significant decline in short interest in May. As of May 15th, there was short interest totalling 18,800 shares, a decline of 5.5% from the April 30th total of 19,900 shares. Based on an average trading volume of 14,000 shares, the short-interest ratio is presently 1.3 days. […]
May 14, 2023
Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 19,900 shares, an increase of 33.6% from the April 15th total of 14,900 shares. Based on an average daily volume of 16,700 shares, the […]
May 14, 2023
Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Rating) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 19,900 shares, a growth of 33.6% from the April 15th total of 14,900 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average […]
May 11, 2023
Presented initial preclinical data from ETX-123, Eliem's lead Kv7 program candidate, demonstrating a promising profile and confirming the proposed...
April 20, 2023
Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Rating) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 24,600 shares, an increase of 25.5% from the March 15th total of 19,600 shares. Currently, 0.1% of the shares of the stock are sold short. Based on […]